Araverus
NewsMarketsResearch
News
HeadlinesThreadsAtlas
© 2026 Araverus
AboutContactPrivacyTerms

Araverus does not provide financial, investment, or trading advice. All content is for informational purposes only. Full disclaimer

  1. News
  2. /
  3. Markets
  4. /
  5. Retail

Albertsons Settles Opioid Claims for $774 Million

Araverus Team|Tuesday, April 14, 2026 at 12:08 PM

Albertsons Settles Opioid Claims for $774 Million

Araverus Team

Apr 14, 2026 · 12:08 PM

Legal Costs · Opioid Settlement · Pharmacy Liability · Retail Pharmacy

Legal CostsOpioid SettlementPharmacy LiabilityRetail Pharmacy

Key Takeaway

Albertsons' $774 million opioid settlement imposes a substantial financial burden, directly impacting its near-term profitability and cash flow over the next nine years. This means increased legal and financial scrutiny for other pharmacy chains and retailers with in-store pharmacies, affecting their operational costs and investor sentiment. It also reinforces the ongoing legal risks within the pharmaceutical and retail pharmacy sectors, signaling continued accountability for past practices.

Albertsons Companies, Inc.

reached a $774 million settlement framework to resolve opioid-related claims brought by state, local, and tribal governments nationwide, resulting in a pre-tax charge of approximately $600 million and a reported operating loss of roughly $480 million last quarter. This settlement, which Albertsons will pay out over nine years, represents one of the most significant financial accountability measures imposed on a major pharmacy chain for its role in the opioid crisis, according to Levin Papantonio attorneys.

Albertsons operates 1,713 in-store pharmacies across its network of 2,244 retail food and drug stores in 35 states and the District of Columbia, under banners including Safeway, Vons, and Jewel-Osco. The company stated the settlement is not an admission of wrongdoing or liability.

The $774 million settlement amount represents approximately 9% of Albertsons' $8.66 billion market capitalization. Levin Papantonio attorneys, including Peter Mougey, Laura Dunning, Page Poerschke, and Jeff Gaddy, were part of the legal team driving accountability in the national opioid litigation, contributing to over $60 billion in recoveries for communities.

Funds from these government opioid lawsuit settlements are directed toward addiction treatment, prevention, and community education.

Read More On

Albertsons Swings to a Loss on Charge From Opioid Settlementwsj.comAlbertsons Swings to Loss on $774 Million Opioid Settlement - mb.ntd.commb.ntd.comAlbertsons Q4, FY2025 report shows loss from opioid settlement - bluebookservices.combluebookservices.comAlbertsons reports Q4 net loss amid $600M opioid charge - grafa.comgrafa.comAlbertsons Swings to Loss After $774M Opioid Settlement - National Todaynationaltoday.com

Related Articles

Markets★★Similarity: 60% · 1d ago

FTC, Ad Companies Agree to Settlement Terms in Boycott Probe

The government began a probe last year into whether ad firms were shifting client spending away from certain media platforms.

Markets★★Similarity: 60% · 4d ago

FTC in Settlement Talks With Ad Companies in Boycott Probe

The government began an inquiry last year into whether ad firms were funneling client dollars away from certain media platforms.

Tech★★★Similarity: 59% · 9d ago

Gilead to Buy German Biotech Tubulis for $3 Billion for Experimental Cancer Drugs

The deal bolsters the California biotech’s pipeline of treatments that aim to deliver chemo in a more targeted way,

Markets★★Similarity: 58% · 8d ago

Constellation Brands Fourth-Quarter Revenue Slides as Alcohol Demand Remains Under Pressure

The U.S. importer of Modelo and Corona logged lower revenue in its latest quarter as demand for its beer, wine and spirits remains weak.